Azacitidine and Nebupent drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Azacitidine and Nebupent together.
The phase IV clinical study analyzes what interactions people who take Azacitidine and Nebupent have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Azacitidine and Nebupent together, and have interactions are studied.
What is Azacitidine?
Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 14,752 Azacitidine users for its effectiveness, alternative drugs and more.
What is Nebupent?
Nebupent has active ingredients of pentamidine isethionate. eHealthMe is studying from 153 Nebupent users for its effectiveness, alternative drugs and more.
Number of Azacitidine and Nebupent reports submitted per year:
Common Azacitidine and Nebupent drug interactions by gender *:
female:
n/a
male:
- Acute myeloid leukaemia
- Disability
* Approximation only. Some reports may have incomplete information.
Do you take Azacitidine and Nebupent?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Azacitidine (14,752 reports)
- Nebupent (153 reports)
Browse all drug interactions of Azacitidine and Nebupent:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Azacitidine side effects:
- Death: 1,043 reports
- Pneumonia: 1,006 reports
- Fever: 872 reports
- Thrombocytopenia (decrease of platelets in blood): 834 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 653 reports
- Sepsis (a severe blood infection that can lead to organ failure and death): 624 reports
Browse all side effects of Azacitidine:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Azacitidine interactions:
- Azacitidine and Allopurinol: 1,815 reports
- Azacitidine and Ondansetron: 942 reports
- Azacitidine and Venclexta: 839 reports
- Azacitidine and Furosemide: 666 reports
- Azacitidine and Cytarabine: 636 reports
- Azacitidine and Pantoprazole: 629 reports
- Azacitidine and Omeprazole: 607 reports
- Azacitidine and Fluconazole: 594 reports
- Azacitidine and Metformin: 537 reports
- Azacitidine and Valacyclovir: 468 reports
Browse all interactions between Azacitidine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on azacitidine and pentamidine isethionate (the active ingredients of Azacitidine and Nebupent, respectively), and Azacitidine and Nebupent (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Azacitidine and Nebupent.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Aldomet and Forteo drug interaction - a second ago
- Flonase Allergy Relief and Micturition Urgency - 2 seconds ago
- Taclonex and Swallowing Difficulty - 12 seconds ago
- Morphabond and Doxycycline drug interaction - 15 seconds ago
- Zoloft and Ocular Myasthenia - 18 seconds ago
- Bortezomib and Foscavir drug interaction - 18 seconds ago
- Paxil and Thrombocytopenic Purpura - 20 seconds ago
- Amlodipine and Sprintec drug interaction - 24 seconds ago
- Visudyne and Circulatory Collapse - 36 seconds ago
- Latuda and Benlysta drug interaction - 40 seconds ago